Eating a nutrient-dense diet, exercising regularly, and prioritizing sleep are foundational habits that not only increase natural GLP-1 levels, but also provide dividends for overall longevity and well-being
Dosage and frequency depend on medical advice based on individual needs
These include risks related to dosing errors in compounded formulations, adverse events reported to the FDA, improper shipping and storage temperature management , and the use of unapproved semaglutide salt forms (semaglutide sodium and semaglutide acetate) in some compounded products
Clinical Evidence: GLP-1 Treatment for NAFLD in the UK Emerging clinical evidence suggests GLP-1 receptor agonists may offer therapeutic benefits for patients with NAFLD and NASH, though it is important to note that these medications are not currently licensed specifically for liver disease treatment in the UK
For borderline results, additional testing with holotranscobalamin or methylmalonic acid/homocysteine levels may be appropriate
